[Development of the protein microarray technique and usefulness in individualized molecular tumor therapy]].
Espina
Virginia
V
Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D014408:Biomarkers, Tumor / Q000235:genetics*; D016503:Drug Delivery Systems; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000235:genetics / Q000401:mortality; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality; D011379:Prognosis; D040081:Protein Array Analysis; D011494:Protein Kinases / Q000235:genetics; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics; D012208:Rhabdomyosarcoma / Q000188:drug therapy / Q000235:genetics / Q000401:mortality; D015398:Signal Transduction / Q000187:drug effects; D015996:Survival Rate; D058570:TOR Serine-Threonine Kinases
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D019253:Proto-Oncogene Proteins c-bcl-2; D011494:Protein Kinases; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases